Outcome of Operated Colorectal Cancers in Relation to the Type of Initial Referral.
cancer
colorectal
colorectal cancer
referral
surgery
target
target referral
two week wait
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
accepted:
28
03
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Aim Since the introduction of the target referral system, there has been controversy about its value and whether it affected the short- and long-term outcomes of colorectal cancer surgeries. With contradicting results, this study highlights differences in personal and tumour characteristics, management differences, and outcomes in each referral pathway, including target pathway referrals for suspected cancers, emergency presentations, routine referrals, and incidentally discovered cancers during screening. Methods A retrospective study of colorectal cancer (CRC) patients operated on between January 1, 2010, and December 31, 2014, with records dating to the end of the five-year follow-up, was extracted anonymously from the database of CRC outcomes at the North Middlesex University Hospital NHS Trust, London. The total number of patients operated on through the four pathways was 176, with full records and competent follow-ups. Patients were classified according to the mode of referral: two-week wait (2WW or target), routine, emergency, and incidental discovery referrals. Comparisons were made between these groups with regard to personal and tumour characteristics, management, and outcome. Results It has been demonstrated by this study that target referrals present mainly with stage I cancers as compared to emergency referrals that present with more stage II (IIa+ IIb+ IIc). The highest percentage of cancer locations within the large bowel was rectal, followed by sigmoid in both target and emergency groups; 8.8% of target patients needed neoadjuvant chemoradiotherapy in the form of FOLFOX (folinic acid, 5-fluorouracil, and oxaliplatin) chemotherapy protocol with the addition of radiotherapy in patients with advanced rectal cancers, compared to 13.3% of emergency patients. Conclusion The colorectal 2WW system was the main pathway supplying colorectal cancer operations; it mostly showed earlier cancers than the other referral groups; its cancers were mostly rectosigmoid with less need for adjuvant chemotherapy; fewer recurrences; and it also showed a lower five-year mortality rate than the emergency group.
Identifiants
pubmed: 37009351
doi: 10.7759/cureus.36840
pmc: PMC10051034
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e36840Informations de copyright
Copyright © 2023, Elnaggar et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Br J Nurs. 2014 Jun 26-Jul 9;23(12):660-7
pubmed: 25039631
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Expert Rev Anticancer Ther. 2015;15(8):963-70
pubmed: 26089093
Surg Endosc. 2018 Aug;32(8):3652-3658
pubmed: 29442241
Ann Intern Med. 1990 Sep 1;113(5):373-84
pubmed: 2200321
Eur J Cancer. 2007 Nov;43(17):2467-78
pubmed: 17931854
J Am Coll Surg. 2011 Sep;213(3):352-61
pubmed: 21737316
Colorectal Dis. 2012 Apr;14(4):e177-80
pubmed: 21920007
CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78
pubmed: 19897840
Colorectal Dis. 2005 Sep;7(5):450-3
pubmed: 16108880
Surgeon. 2013 Jun;11(3):141-6
pubmed: 23238513
Anticancer Res. 2010 Feb;30(2):601-7
pubmed: 20332477
Int J Surg. 2009 Dec;7(6):521-5
pubmed: 19732854
Int J Colorectal Dis. 2018 Jan;33(1):65-69
pubmed: 29101452
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Colorectal Dis. 2007 Mar;9(3):207-9
pubmed: 17298617